Clinical Trial Update: A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Amphotericin B for oral candidiasis in HIV-infected patients who failed fluconazole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis Oral
• HIV Infections

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Candidiasis, Oral, HIV Infections | Phase 2 | Status: COMPLETED